Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma
NCT00226980Phase 2Completed
- Sponsor
- Stanford University
- Start
- Oct 2002
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in renal cell carcinoma (RCC), sponsored by Stanford University. Started Oct 2002; status: completed.
02
Drugs
thalidomide
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00226980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226980.